Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Screening for Postmenopausal Osteoporosis [Internet].

Nelson HD, Helfand M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Sep.

2.

Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force.

Nelson HD, Helfand M, Woolf SH, Allan JD.

Ann Intern Med. 2002 Sep 17;137(6):529-41.

PMID:
12230356
3.
4.

Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet].

Nelson HD, Haney EM, Chou R, Dana T, Fu R, Bougatsos C.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Jul.

5.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

6.

Screening for osteoporosis: an update for the U.S. Preventive Services Task Force.

Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R.

Ann Intern Med. 2010 Jul 20;153(2):99-111. doi: 10.7326/0003-4819-153-2-201007200-00262. Epub 2010 Jul 5. Review.

PMID:
20621892
7.

Bisphosphonates for steroid-induced osteoporosis.

Allen CS, Yeung JH, Vandermeer B, Homik J.

Cochrane Database Syst Rev. 2016 Oct 5;10:CD001347. Review.

PMID:
27706804
8.

Hormone Replacement Therapy and Osteoporosis [Internet].

Nelson HD.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Aug.

9.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

10.
11.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
12.

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR.

JAMA. 1999 Aug 18;282(7):637-45. Erratum in: JAMA 1999 Dec 8;282(22):2124.

PMID:
10517716
13.

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.

Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, Alexandersen P, Zerbini CA, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C; ACTIVE Study Investigators.

JAMA. 2016 Aug 16;316(7):722-33. doi: 10.1001/jama.2016.11136. Erratum in: JAMA. 2017 Jan 24;317(4):442.

PMID:
27533157
14.

Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report [Internet].

Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Suttorp MJ, Motala A, Ewing B, Roth B, Shanman R, Timmer M, Shekelle PG.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar.

15.

Balloon kyphoplasty: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(12):1-45. Epub 2004 Dec 1.

16.

Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.

Avenell A, Mak JC, O'Connell D.

Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227. doi: 10.1002/14651858.CD000227.pub4. Review.

PMID:
24729336
17.

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G.

Cochrane Database Syst Rev. 2003;(4):CD004523. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523.

PMID:
14584020
18.

Management of postmenopausal osteoporosis and the prevention of fractures.

Gambacciani M, Levancini M.

Panminerva Med. 2014 Jun;56(2):115-31. Epub 2014 Jun 19.

19.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523.

PMID:
17636764
20.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171

Supplemental Content

Support Center